AnaptysBio's total assets for Q2 2026 were $316.98M, a decrease of -3.85% from the previous quarter. DE:AN6 total liabilities were $306.40M for the fiscal quarter, a -3.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.